Effects of Simultaneous ETA & AT1 Receptor Antagonism on Endothelial Function & Vascular Stiffness in ANCA-associated Vasculitis

Project Details

StatusActive
Effective start/end date28/10/21 → 27/10/27

Funding

  • Travere Therapeutics: £992,073.01